DTSQ 10-K & 10-Q changes, risk factors and insider trading
DT Cloud Star Acquisition Corp (also DTSQR, DTSQU) · Nasdaq · Blank Checks · CIK 2017950 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Risk Factors
Removed heading “Since we have not yet selected a particular industry or target business with which to complete a business combination, we are unable to currently ascertain the merits or risks of the industry or business in which we may ultimately operate.”
Largest changes
“Since we have not yet selected a particular industry or target business with which to complete a business combination, we are unable to currently ascertain the merits or risks of the industry or business in which we may ultimately operate.”see in full comparison
“Pursuant to the BCA, (a) at the effective time of Redomestication Merger (the “Redomestication Merger Effective Time”), (i) all the issued and outstanding units of DT Cloud Star (the “Parent Units”) immediately prior to the Redomestication Merger Effective Time will separate into their individual components of the ordinary share of DT Cloud Star (the “Parent Ordinary Share”) and the rights of DT Cloud Star (the “Parent Rights”) and will cease separate existence and trading, and (ii) each issued and outstanding Parent Right immediately prior to the Redomestication Merger Effective Time shall …”see in full comparison
In order to meet our working capital needs following the consummation of our initial public offering until completion of an initial business combination or to extend the period of time to consummate a business combination, our initial shareholders, officers and directors or their affiliates may, but are not obligated to, loan us funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion. Each loan would be evidenced by a promissory note. The promissory note would either be paid upon consummation of our initial business combination, without interest, or, at the lender’s discretion, up to $300,000 of the promissory note may be converted upon consummation of our business combination into private units at a price of $10.00 per unit. As such, each promissory note will result in the issuance of 30,000 private units that will result in the issuance of up to an additional 33,333 ordinary shares.see in full comparisonOn October 28, 2024, we issued an unsecured promissory note to the sponsor, pursuant to which we may borrow up to an aggregate principal amount of $300,000 (the “Working Capital Loan Note”). The Working Capital Loan Note is non-interest-bearing and payable on the consummation of the initial business combination or converted upon consummation of the business combination into additional private units at a price of $10.00 per unit. As of December 31, 2024, the principal amount due and owing under the Working Capital Loan Note was $nil. In addition, the potential for the issuance of a substantial number of additional shares upon conversion of the rights could make us a less attractive acquisition vehicle in the eyes of a target business. Such securities, when converted, will increase the number of issued and outstanding ordinary shares and reduce the value of the shares issued to complete the business combination. Accordingly, our rights may make it more difficult to effectuate a business combination or increase the cost of acquiring the target business. Additionally, the sale, or even the possibility of sale, of the shares underlying the rights could have an adverse effect on the market price for our securities or on our ability to obtain future financing. If to the extent these rights are converted, you may experience dilution to your holdings.
“While we intend to focus our search for target businesses on specific locations and industries as described in this Report, we are not limited to those locations and may consummate a business combination with a company in any location or industry we choose. Accordingly, there is no current basis for you to evaluate the possible merits or risks of the particular industry in which we may ultimately operate or the target business which we may ultimately acquire. …”see in full comparison
“On February 2, 2026, we entered into a Business Combination Agreement (the “BCA”) with DTSQ Purchaser Inc., a Delaware corporation and our wholly owned subsidiary (“Purchaser”), DTSQ Merger Sub Inc., a Delaware corporation and our wholly owned subsidiary (“Merger Sub”), and PrimeGen US, Inc., a Delaware corporation (the “Target”). …”see in full comparison
“On October 22, 2025, we entered into an amendment to the Investment Management Trust Agreement (the “Trust Agreement”), with Wilmington Trust National Association. Pursuant to the Trust Agreement, we have the right to extend the time for us to complete our initial business combination for a period for 12 months from October 26, 2025 to October 26, 2026 by depositing into the trust account $75,000 for all remaining public shares for each one-month extension. …”see in full comparison
Full comparison: every changed paragraph (28)
We
are a blank check company with no operating results to date. Therefore, our ability to commence operations is dependent upon obtaining
financing through the public offering of our securities. Since we do not have an operating history, you will have no basis upon which
to evaluate our ability to achieve our business objective, which is to acquire an operating business. We will not generate any revenues
until, at the earliest, after the consummation of a business combination. Further, our executive officers and directors and the majority
shareholder of our sponsor have ties to the PRC and/or are located in the PRC, which may make it more difficult for us to complete an
initial business combination with a target company outside of the PRC, and therefore, make it more likely that we will need to target
a business combination with a target company located in the PRC.
If
we are unable to consummate a business combination, our public shareholders may be forced to wait moreuntil thanOctober 1526, months2026 (unless further
extended) before receiving
liquidation distributions.
We initially have 15 months from the closing of our initial public offering to consummate our initial business combination. On October 22, 2025, we entered into an amendment to the Investment Management Trust Agreement (the “Trust Agreement”), with Wilmington Trust National Association. Pursuant to the Trust Agreement, we have the right to extend the time for us to complete our initial business combination for a period for 12 months from October 26, 2025 to October 26, 2026 by depositing into the trust account $75,000 for all remaining public shares for each one-month extension.
We
will have 15 months from the closing of our initial public offering to complete a business combination. We have no obligation to return
funds to investors prior to such date unless we consummate a business combination prior thereto and only
then in cases where investors
have sought to convert their shares. Only after the expiration of this full time period (unless further
extended) will public shareholders be entitled to liquidation
distributions if we are unable to complete a business combination. Accordingly,
investors’ funds may be unavailable to them until
after such date and to liquidate your investment, you may be forced to sell your
securities potentially at a loss.
On February 2, 2026, we entered into a Business Combination Agreement (the “BCA”) with DTSQ Purchaser Inc., a Delaware corporation and our wholly owned subsidiary (“Purchaser”), DTSQ Merger Sub Inc., a Delaware corporation and our wholly owned subsidiary (“Merger Sub”), and PrimeGen US, Inc., a Delaware corporation (the “Target”). Pursuant to the BCA, subject to the terms and conditions set forth therein, at the closing of the transactions contemplated by the BCA (the “Closing”), (i) we shall merge with and into the Purchaser (the “Redomestication Merger”), with Purchaser surviving the Redomestication Merger; and (ii) at least one business day subsequent to the consummation of the Redomestication Merger, Merger Sub shall merge with and into the Company (the “Acquisition Merger” and together with the Redomestication Merger, the “Mergers”), with the Target surviving the Acquisition Merger (the “Surviving Corporation”). As of the date of issuance of these financial statements, the business combination contemplated by the BCA has not been consummated.
Pursuant to the BCA, (a) at the effective time of Redomestication Merger (the “Redomestication Merger Effective Time”), (i) all the issued and outstanding units of DT Cloud Star (the “Parent Units”) immediately prior to the Redomestication Merger Effective Time will separate into their individual components of the ordinary share of DT Cloud Star (the “Parent Ordinary Share”) and the rights of DT Cloud Star (the “Parent Rights”) and will cease separate existence and trading, and (ii) each issued and outstanding Parent Right immediately prior to the Redomestication Merger Effective Time shall be converted into one right of the Purchaser to receive one-ninth (1/9) of one share of Class A common stock of the Purchaser (the “Purchaser Class A Common Stock”); (b) at the Redomestication Merger Effective Time, each issued and outstanding Parent Ordinary Share, other than certain excluded shares and dissenting shares, immediately prior to the Redomestication Merger Effective Time shall be converted automatically into one share of Purchaser Class A Common Stock; and (c) at the Redomestication Merger Effective Time, Purchaser shall issue warrants to purchase a total of an additional 1,931,900 shares of Purchaser Class A Common Stock (the “Non-Redemption Warrants”) to (x) those DT Cloud Star public shareholders which, as of a time immediately prior to the Redomestication Merger Effective Time, have not tendered their Parent Ordinary Shares in the redemption and (y) all other holders of Parent Ordinary Shares immediately prior to the Redomestication Merger (including, without limitation, the sponsor, other insiders and holders of other Parent Ordinary Shares that are not public Parent Ordinary Shares) (each, an “Eligible Warrant Recipient”).
At the effective time of the Acquisition Merger (the “Acquisition Merger Effective Time”), Purchaser will issue to Company stockholders an aggregate number of Purchaser Class A Common Stock valued at the “Purchase Price,” calculated as (a) $1,489,800,000 less (b) adjustments for outstanding Company warrants (the “Company Warrant”) and Company stock options (the “Company Stock Option”) based on the redemption price less applicable exercise prices. Each share of Purchaser common stock (the “Purchaser Common Stock”) is valued at the redemption price. Each Company stockholder will receive its pro rata share of this “Merger Consideration,” with holders of Company Class A Common Stock (the “Company Class A Common Stock”) receiving Purchaser Class A Common Stock and holders of Company Class B common stock (the “Company Class B Common Stock”) receiving Purchaser Class B common stock (the “Purchaser Class B Common Stock”).
In
order to effectuate a business combination, blank check companies have, in the recent past, amended various provisions of their charters
and governing instruments. For example, blank check companies have amended the definition of business combination, increased redemption
thresholds, and extended the time to consummate a business combination. Amending our amended and restated memorandum and articles of
association will require at least a special resolution of our shareholders as a matter of Cayman Islands law, meaning the approval by
(1) holders of at least two-thirds of our ordinary shares who attend and vote at a general meeting of the company, or (2) a unanimous
written resolution of all of our shareholders. We cannot assure you that we will not seek to amend our amended and restated memorandum
and articles of association or governing instruments or extend the time to consummate an initial business combination in order to effectuate
our initial business combination. In addition, our amended and restated memorandum and articles of association will require us to provide
our public shareholders with the opportunity to redeem their public shares for cash if we propose an amendment to our amended and restated
memorandum and articles of association (a) that would modify the substance or timing of our obligation to provide holders of our public
shares the right to have their shares redeemed or repurchased in connection with our initial business combination or to redeem 100% of
our public shares if we do not complete our initial business combination withinby 15October months26, from2026 the(unless closingfurther ofextended) our initial public offering
or (b) with respect
to any other provision relating to the rights of holders of our public shares.
We
initially have 15 months from the consummationclosing of our initial public offering to completeconsummate anour initial business combination. On October 22,
2025, we entered into an amendment to the Investment Management Trust Agreement (the “Trust Agreement”), with Wilmington
Trust National Association. Pursuant to the Trust Agreement, we have the right to extend the time for us to complete our initial business
combination for a period for 12 months from October 26, 2025 to October 26, 2026 by depositing into the trust account $75,000 for all
remaining public shares for each one-month extension. Any potential target
business with which we enter into negotiations concerning
a business combination will be aware of thisthe requirement.requirement of completion by October 26, 2026 (unless further extended). Consequently, such
target business may obtain leverage over us in negotiating a business combination, knowing that if we do not complete a business combination
with that particular target business, we may be unable to complete a business combination with any other target business. This risk will
increase as we get closer to the time limits referenced above. In addition, we may have limited time to conduct due diligence and may
enter into our initial business combination on terms that we would have rejected upon a more comprehensive investigation.
Since
we have not yet identified any prospective target business, we cannot ascertain the capital requirements for any particular transaction.
If the net proceeds of our initial public offering prove to be insufficient, either because of the size of the business combination,
the depletion of the available net proceeds in search of a target business, or the obligation to convert into cash (or purchase in any
tender offer) a significant number of shares from dissenting shareholders, we will be required to seek additional financing. Such financing
may not be available on acceptable terms, if at all. To the extent that additional financing proves to be unavailable when needed to
consummate a particular business combination, we would be compelled to either restructure the transaction or abandon that particular
business combination and seek an alternative target business candidate. In addition, if we consummate a business combination, we may
require additional financing to fund the operations or growth of the target business. The failure to secure additional financing could
have a material adverse effect on the continued development or growth of the target business. None of our officers, directors or shareholders
is required to provide any financing to us in connection with or after a business combination.
Since
we have not yet selected a particular industry or target business with which to complete a business combination, we are unable to currently
ascertain the merits or risks of the industry or business in which we may ultimately operate.
While
we intend to focus our search for target businesses on specific locations and industries as described in this Report, we are not limited
to those locations and may consummate a business combination with a company in any location or industry we choose. Accordingly, there
is no current basis for you to evaluate the possible merits or risks of the particular industry in which we may ultimately operate or
the target business which we may ultimately acquire. To the extent we complete a business combination with a company in its development
stage, we may be affected by numerous risks inherent in the business operations of those entities. If we complete a business combination
with an entity in an industry characterized by a high level of risk, we may be affected by the currently unascertainable risks of that
industry. Although our management will endeavor to evaluate the risks inherent in a particular industry or target business, we cannot
assure you that we will properly ascertain or assess all of the significant risk factors. We also cannot assure you that an investment
in our units will not ultimately prove to be less favorable to investors in our initial public offering than a direct investment, if
an opportunity were available, in a target business.
A
potential target may make it a closing condition to our business combination that we have a minimum amount of cash at the time of closing.
If the number of our shareholders electing to exercise their redemption rights or sell their shares to us in a tender offer has the effect
of reducing the amount of money available to us to consummate a business combination below such minimum amount required by the target
business and we are not able to locate an alternative source of funding, we will not be able to consummate such business combination
and we may not be able to locate another suitable target within the applicable time period, if at all. In that case, public shareholders
may have to remain shareholders of our company and wait theuntil fullOctober 1526, months,2026 (unless further extended), in order to be able to receive
a pro rata portion
of the trust account, or attempt to sell their shares in the open market prior to such time, in which case
they may receive less than
a pro rata share of the trust account for their shares and suffer an entire loss on your investment.
There
is no requirement under the Companies Act for us to hold annual or general meetings to elect directors. Accordingly, shareholders would
not have the right to such a meeting or election of directors, unless the holders of not less than 10% of the voting rights of our company
request such a meeting. As a result, it is unlikely that there will be an annual general meeting to elect new directors prior to the
consummation of a business combination, in which case all of the current directors will continue in office until at least the consummation
of the business combination. Accordingly, you may not be able to exercise your voting rights foruntil 15the months.consummation of a business combination.
Accordingly, our initial
shareholders will continue to exert control at least until the consummation of a business combination.
Pursuant
to the letter agreement, our initial shareholders, officers and directors have agreed to vote the initial shares owned by them in
favor favor
of our initial business combination. The holders of the representative shares also have agreed, among other things, to vote
their representative
shares in favor of any proposed business combination. As a result, if we sought shareholder approval of a
proposed transaction, we would neednot onlyrequire approximatelyany 35.4%additional ofvotes ourfrom public shares to be
votedshareholders in favor of anthe initialtransaction businessin combinationorder to
have such transaction approved (assuming that all issued and outstanding shares are voted and that the initialinsiders shareholders
do not purchase any
units or shares in the after-market) in order to have our initial business combination approved. Our initial shareholders
currently own approximately 20.0% of our issued and outstanding ordinary shares. Accordingly, if we seek shareholder approval of our
initial business combination, the agreement by our initial shareholders, officers and directors to vote in favor of our initial business
combination will increase the likelihood that we will receive the requisite shareholder approval for such initial business combination..
Our
public shareholders shall be entitled to receive funds from the trust account only in the event of a redemption to public shareholders
prior to any winding up in the event we do not consummate our initial business combination or our liquidation, if they redeem their shares
in connection with an initial business combination that we consummate or if we seek to amend our memorandum and articles of association
to affect the substance or timing of our redemption obligation to redeem all public shares if we cannot complete an initial business
combination withinby 15October months26, of2026 the(unless closingfurther of our initial public offering.extended). In no other circumstances will a shareholder have any right
or interest of
any kind to the funds in the trust account. Holders of rights will not have any right to the proceeds held in the trust
account with
respect to the rights. Accordingly, to liquidate your investment, you may be forced to sell your public shares, potentially
at a loss.
Following
the closing of our initial public offering, $2,069,000 of the net proceeds was released to us and will fund our future working capital
needs. The funds available to us outside of the trust account may not be sufficient to allow us to structure, negotiate or close our
initial business combination, pay our expenses, or to operate for at least theuntil nextOctober 1526, months,2026 (unless further extended), assuming
that our initial business combination
is not consummated during that time. Of the funds available to us, we could use a portion of the
funds available to us to pay fees to
consultants to assist us with our search for a target business. We could also use a portion of the
funds as a down payment or to fund
a “no-shop” provision (a provision in letters of intent designed to keep target businesses
from “shopping” around
for transactions with other companies on terms more favorable to such target businesses) with respect
to a particular proposed business
combination, although we do not have any current intention to do so. If we are unable to fund such
down payments or “no shop”
provisions, our ability to close a contemplated transaction could be impaired. Furthermore, if
we entered into a letter of intent where
we paid for the right to receive exclusivity from a target business and were subsequently required
to forfeit such funds (whether as
a result of our breach or otherwise), we might not have sufficient funds to continue searching for,
or conduct due diligence with respect
to, a target business. In such event, we would need to borrow funds from our insiders, officers,
or directors to operate or may be forced
to liquidate. Our insiders, officers and directors are under no obligation to loan us any funds.
If we are unable to obtain the funds
necessary, we may be forced to cease searching for a target business and may be unable to complete
our initial business combination.
If we are unable to complete our initial business combination, our public shareholders may only receive
a pro rata portion of the amount
then in the trust account (which may be less than $10.00 per share) on our redemption.
In
order to meet our working capital needs following the consummation of our initial public offering until completion of an initial business
combination or to extend the period of time to consummate a business combination, our initial shareholders, officers and directors or
their affiliates may, but are not obligated to, loan us funds, from time to time or at any time, in whatever amount they deem reasonable
in their sole discretion. Each loan would be evidenced by a promissory note. The promissory note would either be paid upon consummation
of our initial business combination, without interest, or, at the lender’s discretion, up to $300,000 of the promissory note may
be converted upon consummation of our business combination into private units at a price of $10.00 per unit. As such, each promissory
note will result in the issuance of 30,000 private units that will result in the issuance of up to an additional 33,333 ordinary shares.
On October 28, 2024, we issued an unsecured promissory note to the sponsor, pursuant to which we may borrow up to an aggregate principal
amount of $300,000 (the “Working Capital Loan Note”). The Working Capital Loan Note is non-interest-bearing and payable on
the consummation of the initial business combination or converted upon consummation of the business combination into additional private
units at a price of $10.00 per unit. As of December 31, 2024, the principal amount due and owing under the Working Capital Loan Note
was $nil. In addition, the potential for the issuance of a substantial number of additional shares upon conversion of the rights
could make us a less attractive acquisition vehicle in the eyes of a target business. Such securities, when converted, will increase
the number of issued and outstanding ordinary shares and reduce the value of the shares issued to complete the business combination.
Accordingly, our rights may make it more difficult to effectuate a business combination or increase the cost of acquiring the target
business. Additionally, the sale, or even the possibility of sale, of the shares underlying the rights could have an adverse effect on
the market price for our securities or on our ability to obtain future financing. If to the extent these rights are converted, you may
experience dilution to your holdings.
On October 28, 2024, we issued an unsecured promissory note to the sponsor, pursuant to which we may borrow up to an aggregate principal amount of $300,000 (the “Working Capital Loan Note”). The Working Capital Loan Note is non-interest-bearing and payable on the consummation of the initial business combination or converted upon consummation of the business combination into additional private units at a price of $10.00 per unit. On July 29, 2025, we entered into a Letter Agreement to the Working Capital Loan Note (the “Letter Agreement”) with the sponsor, pursuant to which we and the sponsor agreed to terminate the Working Capital Loan Note and confirmed that the outstanding amount that we borrowed under the Promissory Note was $nil.
On October 22, 2025, we entered into an amendment to the Investment Management Trust Agreement (the “Trust Agreement”), with Wilmington Trust National Association. Pursuant to the Trust Agreement, we have the right to extend the time for us to complete our initial business combination for a period for 12 months from October 26, 2025 to October 26, 2026 by depositing into the trust account $75,000 for all remaining public shares for each one-month extension. On October 23, 2025, we issued an unsecured promissory note in the aggregate principal amount of $75,000 (the “Note”) to the sponsor, in exchange for its depositing such amount into the our trust account in order to extend the amount of time we have available to complete the business combination. The Note does not bear interest and matures upon the closing of our business combination. In addition, the Note may be converted by the holder into units identical to the units issued in our initial public offering at a price of $10.00 per unit.
In addition, the potential for the issuance of a substantial number of additional shares upon conversion of the rights could make us a less attractive acquisition vehicle in the eyes of a target business. Such securities, when converted, will increase the number of issued and outstanding ordinary shares and reduce the value of the shares issued to complete the business combination. Accordingly, our rights may make it more difficult to effectuate a business combination or increase the cost of acquiring the target business. Additionally, the sale, or even the possibility of sale, of the shares underlying the rights could have an adverse effect on the market price for our securities or on our ability to obtain future financing. If to the extent these rights are converted, you may experience dilution to your holdings.
We
initially have 15 months from the consummation of our initial public offering to consummate the initial business combination. On October
22, 2025, we entered into an amendment to the Investment Management Trust Agreement (the “Trust Agreement”), with Wilmington
Trust National Association. Pursuant to the Trust Agreement, we have the right to extend the time for us to complete our initial business
combination for a period for 12 months from October 26, 2025 to October 26, 2026 by depositing into the trust account $75,000 for all
remaining public shares for each one-month extension. If we do
not complete a business combination withinby 15October months26, from2026 the(unless consummation of our initial public offering,further
extended), we will trigger an automatic
winding up, dissolution and liquidation pursuant to the terms of the amended and restated memorandum
and articles of association. As
a result, this has the same effect as if we had formally gone through a voluntary liquidation procedure
under the Companies Act (As Revised)
of the Cayman Islands. Accordingly, no vote would be required from our shareholders to commence
such a voluntary winding up, dissolution
and liquidation. However, we may extend the period of time to consummate a business. If we are unable to consummate our initial business
combination withinby theOctober
26, 15-month period2026 (unless further extended), we will, as promptly as possible but not more than ten business days
thereafter, redeem 100% of our
outstanding public shares for a pro rata portion of the funds held in the trust account, including a pro
rata portion of any interest
earned on the funds held in the trust account and not necessary to pay taxes, and then seek to liquidate
and dissolve. However, we may
not be able to distribute such amounts as a result of claims of creditors which may take priority over
the claims of our public shareholders.
In the event of dissolution and liquidation, our warrants and rights will expire and will be worthless.
We
are an exempted company incorporated under the laws of the Cayman Islands. In addition, most of our executive officers and directors
are located outside of the United States and are nationals or residents of jurisdictions other than the United States, and most or a
substantial portion of their assets are located outside of the United States. Mr. BianSam Fan,Zheng Sun, our chairman and chief executive officer,
is a PRCUSA passport holder; Mr. Kenneth Lam, our chief financial officer and director, is a United Kingdom passport holder; Ms. Jiayi Liang,
our chief operating officer, is a PRC passport holder; Mr. Shaoke Li, our independent director, is a PRC passport holder; Ms. Longjiao
Li, our independent director, is a PRC passport holder; and Mr. Chi Zhang, our independent director, is a PRC passport holder; and Mr. Xunyong
Zhou, our director, is a PRC passport holder.
Since
the net proceeds of our initial public offering are intended to be used to complete a business combination with a target business that
has not been identified, we may be deemed to be a “blank check” company under the United States securities laws. However,
since we had net tangible assets in excess of $5,000,000 upon the consummation of our initial public offering and we filed a Current
Report on Form 8-K, including an audited balance sheet demonstrating this fact, we are exempt from rules promulgated by the SEC to protect
investors of blank check companies such as Rule 419. Accordingly, investors will not be afforded the benefits or protections of those
rules which would, for example, completely restrict the transferability of our securities, restrict the use of interest earned on the
funds held in the trust account and require us to complete a business combination withinby 15October months26, from2026 the(unless closingfurther of our initial public
offering.extended). Because
we are not subject to Rule 419, our units will be immediately tradable, we will be entitled to withdraw amounts from
the funds held in
the trust account prior to the completion of a business combination and we may have more time to complete an initial
business combination.
In
addition, our directors and officers are nationals or residents of the United Kingdom and the PRC, and most or a substantial portion
of their assets are located in the aforementioned locations. As of the date of this Report, Mr. BianSam Fan,Zheng Sun, our chairman and
chief executive
officer, officer is located in the United States; Ms. Jiayi Liang, our chief operating officer, as well as Mr. Shaoke Li, Ms. Longjiao Li, and Mr. Chi Zhang, our
independent independent
directors, as well as Mr. Xunyong Zhou, our director, are located in the PRC; and Mr. Kenneth Lam, our chief financial
officer and director, is located in the United Kingdom.
Our financial statements contained in the annual report on Form 10-K for the fiscal year ended December 31, 2025 have been audited by an independent registered public accounting firm, Elite CPA P.C., which is headquartered in New Jersey. Elite CPA P.C. is registered with the PCAOB and is subject to laws in the United States, pursuant to which the PCAOB conducts regular inspections to assess its compliance with applicable professional standards.
OurHowever,
financialif statements contained in the annual report on Form 10-K for the fiscal year ended December 31, 2024 have been audited by an
independent registered public accounting firm, UHY LLP, which is headquartered in New York, New York, and has not been identified as
a firm subject to the PCAOB’s determination. UHY LLP is registered with the PCAOB and is subject to laws in the United States,
pursuant to which the PCAOB conducts regular inspections to assess its compliance with applicable professional standards. However, if
it is later determined that the PCAOB is unable to inspect or investigate completely our auditor for two consecutive years because
of of
a position taken by an authority in a foreign jurisdiction, Nasdaq would delist our securities, including our units, ordinary shares
and rights, and the SEC would prohibit them from being traded on a national securities exchange or in the over-the-counter trading market
in the U.S. For example, if we effect our initial business combination with a business located in mainland China and Hong Kong, of which
the auditor is located in mainland China and Hong Kong, with operations in and which performs audit operations in mainland China and
Hong Kong, a jurisdiction where the PCAOB has been unable to conduct inspections without the approval of the relevant authorities, the
work of such auditor as it relates to those operations may not be inspected by the PCAOB. The HFCAA would restrict our ability to consummate
a business combination with a target business unless that business met certain standards of the PCAOB. The HFCAA also requires public
companies to disclose, among other things, whether they are owned or controlled by a foreign government, specifically, those based in
China. Therefore, we may not be able to consummate a business combination with a favorable target business due to relevant laws. Furthermore,
if our securities are delisted and prohibited from being traded on a national securities exchange or in the over-the-counter trading
market in the U.S. for such reasons, it would substantially impair your ability to sell or purchase our securities when you wish to do
so, and the risk and uncertainty associated with potential delisting and prohibition would have a negative impact on the price of our
securities. Such delisting and prohibition could also significantly affect our ability to raise capital on acceptable terms, or at all,
which would have a material adverse effect on our business, financial condition and prospects.
Our
sponsor is predominantly controlled by a MacauPRC national, and we may seek to acquire a company that is based in China in an initial business
combination. The uncertainties in the interpretation and enforcement of PRC laws, rules and regulations would apply to us if we were
to acquire a company that is based in China, regardless of whether we have a direct ownership structure post-business combination. Because
of such ties to China, we may be governed by PRC laws and regulations. PRC companies and variable interest entities are generally subject
to laws and regulations applicable to foreign investments in China and, in particular, laws and regulations applicable to wholly foreign-owned
enterprises. The PRC legal system is based on statutes. Prior court decisions may be cited for reference but have limited precedential
value.
Management's Discussion & Analysis (MD&A)
New heading “Business Combination Agreement”
Largest changes
“Subsequent to December 31, 2025, on February 2, 2026, we entered into a Business Combination Agreement (the “BCA”) with PrimeGen US, Inc. and certain other parties, pursuant to which we intend to consummate our initial business combination through a series of merger transactions. Management believes that the consummation of the proposed business combination, if completed, would provide us with an operating business and additional capital resources. …”see in full comparison
“The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Our management has determined that we have funds that are sufficient to fund the working capital needs of us until the consummation of an initial business combination or the winding up of our company as stipulated in the amended and restated memorandum and articles of association. The accompanying financial statements have been prepared in conformity with U.S. GAAP, which contemplate continuation of our company as a going concern.”see in full comparison
In connection with our assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” our management has determined that if we are unsuccessful in consummating an initial business combination within the prescribed period of time from the closing of our initial public offering, the requirement that we cease all operations, redeem the public shares and thereafter liquidate and dissolve raises substantial doubt about the ability to continue as a going concern.see in full comparisonThe financial statements do not include any adjustments that might result from the outcome of this uncertainty. Our management has determined that we have funds that are sufficient to fund the working capital needs of us until the consummation of an initial business combination or the winding up of our company as stipulated in the amended and restated memorandum and articles of association. The accompanying financial statements have been prepared in conformity with U.S. GAAP, which contemplate continuation of our company as a going concern.
“Our liquidity needs prior to the consummation of the initial public offering were satisfied through the receipt of $25,000 from the sale of the initial shares, as well as a promissory note from our sponsor up to an aggregate amount of $300,000 to be used, in part, for transaction costs incurred in connection with the initial public offering. As of December 31, 2024 and 2023, the principal amount due and owing under the promissory note was $nil and $nil, respectively. …”see in full comparison
“The redemption of public shares, together with the extension of the business combination deadline, provides the Company with additional time to pursue suitable acquisition targets. However, the redemption activity has reduced the amount of cash available outside of the Trust Account, and any further redemptions could further impact the Company’s liquidity position and its ability to consummate the business combination. …”see in full comparison
Full comparison: every changed paragraph (24)
As
indicated in the accompanying financial statements, as of December 31, 2024,2025, we had cash and cash in escrow of $411,429$461 and working capital
deficit of $339,724.$361,245.
Further, Further,
we expect to incur significant costs in the pursuit of our initial business combination.
We cannot assure you that our plans to raise
capital or to complete our initial business combination will be successful.
We initially have 15 months from the closing of our initial public offering to consummate our initial business combination. On October 22, 2025, we entered into an amendment to the Investment Management Trust Agreement (the “Trust Agreement”), with Wilmington Trust National Association. Pursuant to the Trust Agreement, we have the right to extend the time for us to complete our initial business combination for a period for 12 months from October 26, 2025 to October 26, 2026 by depositing into the trust account $75,000 for all remaining public shares for each one-month extension.
WeIf
will have until 15 months from the closing of our initial public offering to complete a business combination. If we anticipate that we
may be unable to consummate our initial business combination within such period, we may seek shareholder approval
to amend our amended
and restated memorandum and articles of association to extend the date by which we must consummate our initial business
combination. combination.
If we seek shareholder approval for an extension, our public shareholders will be offered an opportunity to redeem their
shares at a
per share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest
(net of taxes
payable), divided by the number of then issued and outstanding public shares, subject to applicable laws. If we are unable
to complete
our initial business combination withinby theOctober 15-month26, period2026 or(unless suchfurther period that may be extended,extended), we will (1) cease all operations except for
for the purpose of winding up; (2) as promptly as reasonably possible but no more than ten business days thereafter, redeem 100% of the outstanding
outstanding public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account,
including interest
earned (net of taxes payable), which redemption will completely extinguish public shareholders’ rights as shareholders
(including
the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible
possible following such redemption, subject to the approval of the remaining shareholders and our board of directors, proceed to commence
a voluntary
liquidation and thereby a formal dissolution of our company, subject in each case to its obligations to provide for claims
of creditors
and the requirements of applicable law.
As
of December 31, 2024,2025, we had approximately $411,429$461 in cash and cash in escrow and working capital
capitaldeficit of approximately $339,724.$361,245. We had net income of $1,193,616$2,132,715 for the year ended December
31, 2024,2025, which is mainly from the interest and dividends earned in trust account.
We have incurred and expect to continue to incur significant costs in pursuit of our acquisition plans. We initially have 15 months from the closing of our initial public offering to consummate our initial business combination. On October 22, 2025, we entered into an amendment to the Investment Management Trust Agreement (the “Trust Agreement”), with Wilmington Trust National Association. Pursuant to the Trust Agreement, we have the right to extend the time for us to complete our initial business combination for a period for 12 months from October 26, 2025 to October 26, 2026 by depositing into the trust account $75,000 for all remaining public shares for each one-month extension.
Our
liquidity needs prior to the consummation of the initial public offering were satisfied through the receipt of $25,000 from the sale
of the initial shares, as well as a promissory note from our sponsor up to an aggregate amount of $300,000 to be used, in part, for transaction
costs incurred in connection with the initial public offering. As of December 31, 2024 and 2023, the principal amount due and owing under
the promissory note was $nil and $nil, respectively.
Subsequent to the consummation of the initial public offering, our liquidity has been satisfied through the net proceeds from the consummation
of the initial public offering and the private placement held outside of the trust account. In addition, in order to finance transaction
costs in connection with a business combination, sponsor, officers, directors, or their affiliates may provide us with working capital
loans as may be required (of which up to $300,000 may be converted into units). See “—Liquidity and Capital Resources”
for details.
WeIf
have incurred and expect to continue to incur significant costs in pursuit of our acquisition plans. We initially had 15 months from
the consummation of our initial public offering to consummate the initial business combination. If we do not complete a business combination
within 15by monthsOctober from26, the2026 consummation(unless offurther our initial public offering,extended), we will trigger an automatic winding up, dissolution
and liquidation
pursuant to the terms of the amended and restated memorandum and articles of association. As a result, this has the same
effect as if
we had formally gone through a voluntary liquidation procedure under the Companies Act (As Revised) of the Cayman Islands.
Accordingly, Accordingly,
no vote would be required from our shareholders to commence such a voluntary winding up, dissolution and liquidation. However, we mayIf
extend the period of time to consummate a business combination. If we are unable to consummate our initial business combination within
theby 15-monthOctober period26, 2026 (unless further extended), we will, as promptly as possible
but not more than ten business days thereafter, redeem
100% of our outstanding public shares for a pro rata portion of the funds held
in the trust account, including a pro rata portion of
any interest earned on the funds held in the trust account and not necessary to
pay taxes, and then seek to liquidate and dissolve. However,
we may not be able to distribute such amounts as a result of claims of creditors
which may take priority over the claims of our public
shareholders. In the event of dissolution and liquidation, our warrants and rights
will expire and will be worthless.
In
connection with our assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15,
“Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” our management has determined
that if we are unsuccessful in consummating an initial business combination within the prescribed period of time from the closing of
our initial public offering, the requirement that we cease all operations, redeem the public shares and thereafter liquidate and dissolve
raises substantial doubt about the ability to continue as a going concern. The financial statements do not include any adjustments that
might result from the outcome of this uncertainty. Our management has determined that we have funds that are sufficient to fund the working
capital needs of us until the consummation of an initial business combination or the winding up of our company as stipulated in the amended
and restated memorandum and articles of association. The accompanying financial statements have been prepared in conformity with U.S.
GAAP, which contemplate continuation of our company as a going concern.
Business Combination Agreement
Subsequent to December 31, 2025, on February 2, 2026, we entered into a Business Combination Agreement (the “BCA”) with PrimeGen US, Inc. and certain other parties, pursuant to which we intend to consummate our initial business combination through a series of merger transactions. Management believes that the consummation of the proposed business combination, if completed, would provide us with an operating business and additional capital resources. However, the completion of the proposed business combination is subject to customary closing conditions, including regulatory approvals and shareholder approval, and there can be no assurance that the transaction will be consummated. Accordingly, the matters described above do not alleviate the substantial doubt about our ability to continue as a going concern.
The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Our management has determined that we have funds that are sufficient to fund the working capital needs of us until the consummation of an initial business combination or the winding up of our company as stipulated in the amended and restated memorandum and articles of association. The accompanying financial statements have been prepared in conformity with U.S. GAAP, which contemplate continuation of our company as a going concern.
For the year ended December 31, 2025, cash used by operating activities was $410,968, primarily due to prepayment of formation and operational costs. As of December 31, 2025, we had cash at bank of $461.
For
the year ended December 31, 2024, cash used by operating activities was $196,752, primarily due to prepayment of formation and operational
costs. Net cash used in investing activates was $69,000,000 to invest the cash in a trust account established for the benefit of our
public shareholders, with Wilmington Trust National Association acting as trustee. Net cash provided by financing activities was $69,608,181,
primarily due to the consummation the IPO of 6,900,000 units at $10.00 per unit, generating gross proceeds of $69,000,000 and the proceeds
from sale of units to the founder in private placement generating total gross proceeds of $2,069,000. Offering cost amounted to $1,485,819,
consisting of $1,035,000 of underwriting commissions and $450,819 of other offering costs. As of December 31, 2024, we had cash at bank
of $411,429.
On
December 31, 2024,2025, the Company had working capital deficit of $339,724,$361,245, excluding deferred
underwriting commissions and the available cash held
in the Trust Account for marketable securities, which indicated a lack of liquidity
it needed to sustain operations for a reasonable
period of time, which was considered to be one year from the issuance of the financial
statements.
In
order to fund working capital deficiencies or finance transaction costs in connection with an initial business combination, our sponsor,
officers, directors, or their affiliates may, but are not obligated to, loan us funds as may be required. If we complete our initial
business combination, we will repay such loaned amounts. In the event that the initial business combination does not close, we may use
a portion of the working capital held outside the trust account to repay such loaned amounts, but no proceeds from our trust account
would be used for such repayment. Up to $300,000 of such loans may be convertible upon consummation of the initial business combination
into private units at a price of $10.00 per unit.
On
October 28, 2024, we issued an unsecured promissory note to the sponsor, pursuant to which we may borrow up to an aggregate principal
amount of $300,000 (the “Working Capital Loan Note”). The Working Capital Loan Note is non-interest-bearing and payable on
the consummation of the initial business combination or converted upon consummation of the business combination into additional private
units at a price of $10.00 per unit. AsOn ofJuly December29, 31,2025, 2024,we theentered principalinto amounta dueLetter andAgreement owing underto the Working Capital Loan Note (the “Letter
Agreement”) with the sponsor, pursuant to which we and the sponsor agreed to terminate the Working Capital Loan Note and confirmed
that the outstanding amount that we borrowed under the Promissory Note was $nil.
On October 22, 2025, we entered into an amendment to the Investment Management Trust Agreement (the “Trust Agreement”), with Wilmington Trust National Association. Pursuant to the Trust Agreement, we have the right to extend the time for us to complete our initial business combination for a period for 12 months from October 26, 2025 to October 26, 2026 by depositing into the trust account $75,000 for all remaining public shares for each one-month extension. On October 23, 2025, we issued an unsecured promissory note in the aggregate principal amount of $75,000 (the “Note”) to the sponsor, in exchange for its depositing such amount into the our trust account in order to extend the amount of time we have available to complete the business combination. The Note does not bear interest and matures upon the closing of our business combination. In addition, the Note may be converted by the holder into units identical to the units issued in our initial public offering at a price of $10.00 per unit. As of December 31, 2025, we have issued additional unsecured promissory notes to the sponsor in connection with subsequent one-month extensions, resulting in an aggregate principal amount of $150,000 deposited into the trust account for business combination extension purposes.
Additionally, during the shareholder meeting, a total of 5,247,491 shares of common stock were tendered for redemption. This redemption of public shares resulted in a significant reduction in the number of outstanding public shares and has impacted the Company’s available liquidity. Management is actively managing the Company’s cash resources to ensure that sufficient funds are available to meet the minimum cash condition required to consummate the business combination.
The redemption of public shares, together with the extension of the business combination deadline, provides the Company with additional time to pursue suitable acquisition targets. However, the redemption activity has reduced the amount of cash available outside of the Trust Account, and any further redemptions could further impact the Company’s liquidity position and its ability to consummate the business combination. To support its ongoing liquidity needs and fund operating and transaction-related expenses, the Company plans to issue additional promissory notes to the Sponsor or its affiliates, subject to mutually agreed terms. The Company will continue to closely monitor its liquidity position and take appropriate actions to ensure that it maintains sufficient capital resources to complete the business combination.
Subsequent to December 31, 2025, on February 2, 2026, we entered into a Business Combination Agreement (the “BCA”) with PrimeGen US, Inc. and certain other parties, pursuant to which we intend to consummate our initial business combination. As the proposed business combination had not been consummated as of December 31, 2025, the execution of the BCA did not have any impact on our results of operations for the year ended December 31, 2025. Accordingly, we did not recognize any revenues related to the target business during the period, and our expenses continued to primarily consist of legal, accounting, advisory and other professional fees incurred in connection with identifying and evaluating a target business and preparing for the proposed business combination.
The
preparation of financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial
statements, and the reported amounts of income and expenses during the periods reported. Actual results could materially differ from
those estimates. A critical accounting estimate to our financial statements includes the valuation of ordinary shares subject to possible
redemption. We have not identified any critical accounting estimates.
A critical accounting estimate to our financial statements includes the valuation of ordinary shares subject to possible redemption. We have not identified any critical accounting estimates.
In connection with the proposed business combination, management has estimated the costs related to the transaction, which include legal, accounting, advisory, and other professional fees. These costs are expensed as incurred and are subject to change depending on the final structure of the business combination and the parties involved. The Company has not yet finalized the total amount of transaction costs, which will be reflected in the financial statements upon the consummation of the business combination.
Our
management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have
a material effect on our unauditedaudited financial statements.
What changed in the latest 10-Q
Risk Factors
Largest changes
“On January 15, 2026, we were notified by the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) that based on our Market Value of Listed Securities (“MVLS”) for the period from November 21, 2025 to January 6, 2026, we no longer met the continued listing requirement under Nasdaq Listing Rule 5450(b)(2)(A) to maintain a minimum MVLS of $50,000,000. On April 6, 2026, we were notified by Nasdaq that we did not comply with the minimum 400 total shareholders requirement for continued inclusion under Nasdaq Listing Rule 5450(a)(2). …”see in full comparison
“On April 6, 2026, we received a Nasdaq deficiency notice related to non-compliance with the minimum public shareholder requirement under Listing Rule 5450 (a)(2). If the Company are unable to regain compliance within the allowed grace period, Nasdaq may initiate delisting proceedings against our ordinary shares. Any delisting would materially reduce stock liquidity and adversely affect the market price of our securities.”see in full comparison
see in full comparisonFailureWe may not be able toMaintainmaintain compliance with NasdaqListinglistingCompliancerequirements.
Full comparison: every changed paragraph (3)
FailureWe
may not be able to Maintainmaintain compliance with Nasdaq Listinglisting Compliancerequirements.
On January 15, 2026, we were notified by the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) that based on our Market Value of Listed Securities (“MVLS”) for the period from November 21, 2025 to January 6, 2026, we no longer met the continued listing requirement under Nasdaq Listing Rule 5450(b)(2)(A) to maintain a minimum MVLS of $50,000,000. On April 6, 2026, we were notified by Nasdaq that we did not comply with the minimum 400 total shareholders requirement for continued inclusion under Nasdaq Listing Rule 5450(a)(2). Based on the review of materials we submitted on May 29, 2026, Nasdaq granted our request for an extension until October 5, 2026 to regain compliance with this requirement. On July 15, 2026, we received written notice from the Listing Qualifications Department of Nasdaq stating that Nasdaq had determined to delist our securities due to our failure to regain compliance with Nasdaq Listing Rules. Unless we requested an appeal by July 22, 2026, trading of our securities would be suspended at the opening of business on July 24, 2026, and a Form 25-NSE would be filed with the SEC to remove our securities from listing and registration on Nasdaq. We timely submitted a hearing request, which stayed the suspension. On July 27, 2026, we received notice that Nasdaq approved the transfer of the listing of our ordinary shares, units and rights from the Nasdaq Global Market to the Nasdaq Capital Market, effective at the opening of trading on July 29, 2026. As a result of this transfer, we regained compliance with Nasdaq listing requirements. Our securities continue to trade under the symbols “DTSQ,” “DTSQU” and “DTSQR,” respectively. However, there can be no assurance that we will be able to maintain compliance with Nasdaq listing requirements in the future. Any delisting from Nasdaq would materially reduce stock liquidity and adversely affect the market price of our securities.
On
April 6, 2026, we received a Nasdaq deficiency notice related to non-compliance with the minimum public shareholder requirement under
Listing Rule 5450 (a)(2). If the Company are unable to regain compliance within the allowed grace period, Nasdaq may initiate delisting
proceedings against our ordinary shares. Any delisting would materially reduce stock liquidity and adversely affect the market price
of our securities.
Management's Discussion & Analysis (MD&A)
Largest changes
“Subsequent to the quarter ended June 30, 2026, on July 29, 2026, the Company completed the transfer of its listed securities from the Nasdaq Global Market to the Nasdaq Capital Market, following Nasdaq’s approval received on July 27, 2026. …”see in full comparison
“On April 6, 2026, the Company received a deficiency notice from Nasdaq stating that it no longer complies with Nasdaq Listing Rule 5450 (a)(2), which requires a minimum of 400 public shareholders for continued listing on the Nasdaq Global Market. The Company has until May 21, 2026 to submit a compliance plan, and may be granted up to 180 days from the notice date to regain compliance if the plan is accepted. The Company is evaluating strategic alternatives, including a potential transfer to the Nasdaq Capital Market. …”see in full comparison
“For the three months ended March 31, 2026, we had net loss of $110,289, which consisted of operating costs of $268,316, offset by interest and dividends earned on marketable securities held in the operating account and Trust Account of $158,027. For the three months ended March 31, 2025, we had net income of $630,284, which consisted of operating costs of $110,859, offset by interest and dividends earned on marketable securities held in the operating account and Trust Account of $741,143.”see in full comparison
“For the six months ended June 30, 2026, we had net loss of $74,754, which consisted of operating costs of $394,383, offset by interest earned on marketable securities held in the operating account and Trust Account of $319,629. For the six months ended June 30, 2025, we had net income of $1,261,782, which consisted of operating costs of $223,570, offset by interest and dividends earned on marketable securities held in the operating account and Trust Account of $1,485,352.”see in full comparison
For thesee in full comparisonthreesix months endedMarchJune31,30, 2026, cashprovidedusedbyin operating activities was$1,195,$120, primarily due to the Company’s operating expenditures, which offset payments made by thesponsor, which offset the Company’s operating expendituressponsor during the period. As ofMarchJune31,30, 2026, we had cash at bank of$1,656.$341.
In order to fund working capital deficiencies or finance transaction costs in connection with an initial business combination, our sponsor, officers, directors, or their affiliates may, but are not obligated to, loan us funds as may be required. If we complete our initial business combination, we will repay such loaned amounts. In the event that the initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts, but no proceeds from our trust account would be used for such repayment.see in full comparisonUp to $300,000 of such loans may be convertible upon consummation of the initial business combination into private units at a price of $10.00 per unit.
Full comparison: every changed paragraph (10)
For
the threesix months ended MarchJune 31,30, 2026, cash providedused byin operating activities was $1,195,$120, primarily due to the Company’s operating expenditures,
which offset payments made by the sponsor,
which offset the Company’s operating expendituressponsor during the period. As of MarchJune 31,30, 2026, we had cash at bank of $1,656.$341.
On
MarchJune 31,30, 2026, the Company had working capital deficit of $854,550,$980,611, excluding deferred underwriting commissions and the available cash
held in the Trust Account for marketable securities, which indicated a lack of liquidity it needed to sustain operations for a reasonable
period of time, which was considered to be one year from the issuance of the financial statements.
In
order to fund working capital deficiencies or finance transaction costs in connection with an initial business combination, our sponsor,
officers, directors, or their affiliates may, but are not obligated to, loan us funds as may be required. If we complete our initial
business combination, we will repay such loaned amounts. In the event that the initial business combination does not close, we may use
a portion of the working capital held outside the trust account to repay such loaned amounts, but no proceeds from our trust account
would be used for such repayment. Up to $300,000 of such loans may be convertible upon consummation of the initial business combination
into private units at a price of $10.00 per unit.
We
have neither engaged in any operations nor generated any revenue to date. Our entire activity since inception through MarchJune 31,30, 2026 related
related to our formation, the preparation for the initial public offering, and since the closing of the initial public offering, the
search for
a prospective initial business combination. We do not expect to generate any operating revenues until the closing and completion
of our
initial business combination, at the earliest. We will generate non-operating income in the form of interest income from the amount held
held in the trust account. We expect that we will incur increased expenses as a result of being a public company (for legal, financial reporting,
reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with search for, and completing,
a business
combination.
For the six months ended June 30, 2026, we had net loss of $74,754, which consisted of operating costs of $394,383, offset by interest earned on marketable securities held in the operating account and Trust Account of $319,629. For the six months ended June 30, 2025, we had net income of $1,261,782, which consisted of operating costs of $223,570, offset by interest and dividends earned on marketable securities held in the operating account and Trust Account of $1,485,352.
For
the three months ended March 31, 2026, we had net loss of $110,289, which consisted of operating costs of $268,316, offset by interest
and dividends earned on marketable securities held in the operating account and Trust Account of $158,027. For the three months ended
March 31, 2025, we had net income of $630,284, which consisted of operating costs of $110,859, offset by interest and dividends earned
on marketable securities held in the operating account and Trust Account of $741,143.
The
preparation of financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial
statements, and the reported amounts of income and expenses during the periods reported. Actual results could materially differ from
those estimates. A critical accounting estimate to our unaudited financial statements includes the valuation of ordinary shares subject
to possible redemption. We have not identified any critical accounting estimates.
As
of MarchJune 31,30, 2026, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.
Subsequent to the quarter ended June 30, 2026, on July 29, 2026, the Company completed the transfer of its listed securities from the Nasdaq Global Market to the Nasdaq Capital Market, following Nasdaq’s approval received on July 27, 2026. This transfer was initiated to address previously reported deficiencies in the Company’s compliance with the Global Market continued listing standards and has successfully restored the Company’s compliance at the Capital Market tier, which imposes lower quantitative thresholds for stockholders’ equity, market value of publicly held shares, and minimum bid price. While this transfer has resolved the immediate risk of delisting, management cautions that there can be no assurance that the Company will be able to maintain compliance with the Capital Market’s ongoing listing requirements in the future. A future delisting from Nasdaq, if it were to occur, would materially reduce the trading liquidity of the Company’s ordinary shares, units and rights, and would adversely affect their market prices, as well as potentially impair the Company’s access to capital markets. Management intends to continue monitoring the Company’s key financial metrics against the Capital Market continued listing standards and will evaluate available remedial measures, if necessary. However, there is no guarantee that any such measures would be successful or that the Company would avoid future non-compliance. This listing transfer does not have any direct impact on the Company’s reported results of operations, cash flows, or financial position for the quarter ended June 30, 2026.
On
April 6, 2026, the Company received a deficiency notice from Nasdaq stating that it no longer complies with Nasdaq Listing Rule 5450
(a)(2), which requires a minimum of 400 public shareholders for continued listing on the Nasdaq Global Market. The Company has until
May 21, 2026 to submit a compliance plan, and may be granted up to 180 days from the notice date to regain compliance if the plan is
accepted. The Company is evaluating strategic alternatives, including a potential transfer to the Nasdaq Capital Market. There can be
no assurance that the Company will successfully regain compliance or maintain its Nasdaq listing. The Company filed a Form 8-K with the
SEC on April 9, 2026 to disclose this matter.
DTSQ insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
No Form 4 stock transactions in this period.
Well-known investors holding DTSQ (13F)
| Investor | Quarter | Shares | Reported value | % of their 13F | Change vs prior quarter |
|---|---|---|---|---|---|
| D. E. Shaw & Co. | 2026-06-30 | 150,000 | $16.5K | 0.0% | No change |